Small cap wrap: Purepoint Uranium, Custom Health, Standard Uranium, Blockmate
Purepoint Uranium approved a 2027 exploration plan for its Dorado project. Custom Health reported 220% revenue growth to US$14.4M. Standard Uranium confirmed geology at its Rocas project. Blockmate Ventures ordered its first NVIDIA B200 compute node. 374Water saw 83% revenue increase. Allergy Therapeutics plans to delist from AIM. Pantheon Resources raised £7.5M. IXICO developed an AI tool for Alzheimer's drug safety checks.


